America July 18, 2023
Revolutionary Alzheimer’s Drug, Donanemab, Shows Promise in Slowing Disease Progression
In a groundbreaking development, Eli Lilly, a US-based pharmaceutical company, has released the final results of trials on donanemab, a…
America July 18, 2023
In a groundbreaking development, Eli Lilly, a US-based pharmaceutical company, has released the final results of trials on donanemab, a…
By Jackie Allen
America June 19, 2023
A groundbreaking research study conducted by the University of Haifa and the Max Stern Yezreel Valley College in Israel has…
By Jackie Allen